According to the GMI Research, the Travel Vaccines Market will enlarge at a faster rate during the forecast period. This is because of the rising incidences of contagious diseases, rapid globalization resulting in increasing international travel activities, and amelioration in healthcare infrastructure.
Request a free sample of the Global Travel Vaccines Market
Introduction of the Travel Vaccines Market
Travel vaccines or travel immunizations refer to the dosage given to travelers before visiting any regions across the nation to protect them from catching any severe disease. This process works by manifesting the body to the germs of the specific disease. The body further creates a response to the vaccination by producing antibodies to prevent the body when subjected to the disease.
Travel Vaccines Market Dynamics
The accelerating number of issues concerned with health and ongoing technological modernizations are the prime factors supplementing the growth of the global travel vaccines market. Also, the strategic initiatives by the government, such as allowance, to develop vaccines have impelled the market growth. Moreover, as per the Global Travel Vaccines Market Report, the rising consciousness concerned with the diseases that can be controlled by vaccines and the enlargement of the healthcare sector will further pave the way for market growth. Furthermore, the accelerating number of travelers resulting in increasing incidences of diseases has fuelled the market growth. However, inflated cost, as well as the excessive initial investment required for the establishment of the travel vaccine, has hampered the Travel Vaccines Market Size.
North America is projected to lead the travel vaccines market over the forecast period. The United States is one of the least impacted countries in the pandemic, which plays a crucial role in driving the market growth.
Based on product, vaccines for meningococcus bacteria will hold a larger share over the forecast period. Europe will exhibit a significant growth with excessive expenditure on research and development.
Travel Vaccines Market Segmentation:
Segmentation by Type
· Monovalent Vaccines
· Combination Vaccines
Segmentation by Technology
· Conjugate Vaccines
· Live Attenuated Vaccines
· Inactivated & Subunit Vaccines
· Recombinant Vaccines
· DNA Vaccines
· Toxoid Vaccines
Segmentation by Disease
· Hepatitis A
· Hepatitis B
· Rabies
· Typhoid
· Japanese Encephalitis
· Yellow Fever
· Meningococcal
· DPT
· Varicella
· Influenza
· Others
Segmentation by Region:
· Europe
o United Kingdom
o Germany
o France
o Spain
o Rest of Europe
· Asia Pacific
o China
o Japan
o India
o Rest of APAC
· North America
o United States of America
o Canada
· RoW
o UAE
o Brazil
o South Africa
o Saudi Arabia
About GMI Research
GMI Research is a market research and consulting firm which provides market insights and intelligence across 12 major sectors helping our clients in making effective investment and business decisions.
Media Contact
Company Name: GMI RESEARCH
Contact Person: Sarah Nash
Email: enquiry@gmiresearch.com
Phone: Europe – +353 1 442 8820; US – +1 860 881 2270
Address: Dublin, Ireland
Website: www.gmiresearch.com